Pulmonary hypertension

LE WE PMID CA

Pulmonary hypertension

3003

Pulmonale Hypertonie

Ambrisentan

Anemia (Sickle cell)

Angiogenesis

Asthma (occupational)

Blood vessels (Vasoconstriction)

BNP

Bosentan

Calcium (Capacitative transport)

Caveolin and caveoles

COPD

DHEA

Eisenmenger s syndrome

Endothelial dysfunction

Endothelin

Epoprostenol

Extrinsic compression of the left main coronary artery

Guanosine triphosphate cyclohydrolase

Guanylat cyclase

Heart (Coronary heart disease BASKET)

Heart (Echocardiography)

Heart (Imaging)

Heart (Inherited and congenital diseases in grown up patients)

Heart (Transplantation)

Heart failure (BASKET)

Heart failure (Right sided)

Hypoxic pulmonary vasoconstriction

Iloprost

Ion channel (Potassium)

Lung (Anatomy)

Lung (Fibrosis)

Lung (Infarct)

Lung (Transplantation)

Lung and bronchial system (Malformation)

Mitochondria (BASKET)

N methylsulfonyl 2 2 propynyloxy benzenehexanamide ttP450epoxygenase

Nitrates and prodrugs (Pharmacology)

Nitric oxide NO

Nitrite reductase

Oxygen (Hypoxia)

PDE phosphodiesterase

PDE5

Prostacyclin

Pulmonary embolism

Pulmonary emphysema

Pulmonary function testing

Pulmonary hypertension

Redox (BASKET)

Rho kinase

Sarcoidosis

Sclerodermia

Sildenafil

Sitaxsentan

Smooth muscle

Tadalafil

Thorax (Pain)

Treprostinil

TRPC6

TRPV4

2007 1	Psychosocial aspects of pulmonary hypertension: a review. [18071092] Psychosomatics 48(6): 467-75 (2007)
2007 2	Pulmonary arterial hypertension: evaluation and management. [17458400] South Med J 100(4): 393-9 (2007)
1993 3	Pulmonary hypertension and cor pulmonale. [8211354] South Med J 86(10): 2S7-10 (1993)
2008 4	Mechanisms responsible for pulmonary hypertension. [19187603] Chin Med J (Engl) 121(24): 2604-9 (2008)
2005 5	Current treatment strategies for pulmonary arterial hypertension. [16115293] J Intern Med 258(3): 199-215 (2005)
2002 6	Primary pulmonary hypertension. [12164370] Neth J Med 60(3): 133-9 (2002)
2007 7	Diagnostic strategies for suspected pulmonary arterial hypertension: a primer for the internist. [17941295] Cleve Clin J Med 74(10): 737-47 (2007)
2003 8	Diagnosis and evaluation of pulmonary hypertension. [12716138] Cleve Clin J Med 70 Suppl 1(-): S9-17 (2003)
2003 9	Primary pulmonary hypertension: an overview of epidemiology and pathogenesis. [12716137] Cleve Clin J Med 70 Suppl 1(-): S2-8 (2003)
2003 10	Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists. [12760982] Anesth Analg 96(6): 1603-16 (2003)
2003 11	Pulmonary arterial hypertension: pathophysiology and anesthetic approach. [14639158] Anesthesiology 99(6): 1415-32 (2003)
2007 12	Chronic thromboembolic pulmonary hypertension (CTEPH). [17699182] Heart 93(9): 1152-8 (2007)
2005 13	Pulmonary artery dissection: an emerging cardiovascular complication in surviving patients with chronic pulmonary hypertension. [15657218] Heart 91(2): 142-5 (2005)
2009 14	Pulmonary hypertension in idiopathic pulmonary fibrosis: a review. [19960783] Sarcoidosis Vasc Diffuse Lung Dis 26(1): 7-19 (2009)
2009 15	The effects of vasodilators in pulmonary hypertension: pulmonary vascular or peripheral vascular? [19808330] Circ Heart Fail 2(2): 145-50 (2009)
2010 16	Endothelin receptor antagonists for pulmonary arterial hypertension: an overview. [20406243] Cardiovasc Ther 28(5): e65-71 (2010)
2010 17	The emergence of oral tadalafil as a once-daily treatment for pulmonary arterial hypertension. [20479949] Vasc Health Risk Manag 6(-): 273-80 (2010)
2009 18	RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension. [19707285] Vasc Health Risk Manag 5(-): 663-71 (2009)
2009 19	Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient. [19688101] Vasc Health Risk Manag 5(-): 607-19 (2009)
2009 20	Treatment of pediatric pulmonary hypertension. [19554091] Vasc Health Risk Manag 5(2): 509-24 (2009)
2009 21	Inhaled iloprost for the control of pulmonary hypertension. [19475782] Vasc Health Risk Manag 5(1): 465-74 (2009)
2009 22	Review of inhaled iloprost for the control of pulmonary artery hypertension in children. [19436672] Vasc Health Risk Manag 5(1): 325-31 (2009)
2008 23	Treprostinil for pulmonary hypertension. [18827901] Vasc Health Risk Manag 4(3): 507-13 (2008)
2007 24	Review of bosentan in the management of pulmonary arterial hypertension. [18200808] Vasc Health Risk Manag 3(6): 887-900 (2007)
2007 25	A review of sitaxsentan sodium in patients with pulmonary arterial hypertension. [17583185] Vasc Health Risk Manag 3(1): 151-7 (2007)
2007 26	A review of pulmonary arterial hypertension: role of ambrisentan. [17583171] Vasc Health Risk Manag 3(1): 11-22 (2007)
2007 27	DHEA treatment of pulmonary hypertension: new insights into a complex mechanism. [17466961] Cardiovasc Res 74(3): 337-8 (2007)
2004 28	The endothelin system in pulmonary arterial hypertension. [14736539] Cardiovasc Res 61(2): 227-37 (2004)
1999 29	Role of endothelial and smooth muscle cells in the physiopathology and treatment management of pulmonary hypertension. [10690304] Cardiovasc Res 44(2): 274-82 (1999)
1997 30	Pulmonary hypertension: updating a mysterious disease. [9205539] Cardiovasc Res 34(2): 268-72 (1997)
2008 31	Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension. [18536743] Br J Pharmacol 155(4): 444-54 (2008)
2008 32	Pulmonary hypertension: therapeutic targets within the serotonin system. [18536742] Br J Pharmacol 155(4): 455-62 (2008)
2000 33	5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. [10991906] Br J Pharmacol 131(2): 161-8 (2000)
2007 34	Diagnostics in pulmonary hypertension. [18204173] J Physiol Pharmacol 58 Suppl 5(Pt 2): 591-602 (2007)
2009 35	Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent. [20054445] Drug Des Devel Ther 3(): 269-87 (2009)
2009 36	Ambrisentan for the treatment of pulmonary arterial hypertension. [19920913] Drug Des Devel Ther 2(-): 265-80 (2009)
2009 37	Clinical and cost-effectiveness of epoprostenol, iloprost, bosentan, sitaxentan and sildenafil for pulmonary arterial hypertension within their licensed indications: a systematic review and economic evaluation. [19863849] Health Technol Assess 13(49): 1-320 (2009)
2010 38	Optimising the management of pulmonary arterial hypertension patients: emergency treatments. [20956193] Eur Respir Rev 19(117): 204-11 (2010)
2010 39	Emergency treatments in pulmonary arterial hypertension: a place for algorithms and for education programmes. [20956189] Eur Respir Rev 19(117): 171-2 (2010)
2007 40	Recent progress in the treatment of pulmonary arterial hypertension: expectation for rho-kinase inhibitors. [17409670] Tohoku J Exp Med 211(4): 309-20 (2007)
2000 41	Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension. [11015616] Physiol Rev 80(4): 1337-72 (2000)
2005 42	Evaluation and management of the patient with pulmonary arterial hypertension. [16103472] Ann Intern Med 143(4): 282-92 (2005)
2008 43	The management of pulmonary hypertension in children. [18381346] Arch Dis Child 93(7): 620-5 (2008)
2005 44	Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. [16320330] Arthritis Rheum 52(12): 3792-800 (2005)
2002 45	Pulmonary hypertension in autoimmune rheumatic diseases: where are we now? [12209501] Arthritis Rheum 46(8): 1997-2009 (2002)
1964 46	PRIMARY PULMONARY HYPERTENSION: A REVIEW, AND REPORT OF FIVE CASES. [14180523] Can Med Assoc J 91(-): 145-53 (1964)
2008 47	Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor. [19059957] Chest 134(6): 1271-7 (2008)
2008 48	ECG monitoring of treatment response in pulmonary arterial hypertension patients. [18641107] Chest 134(6): 1250-7 (2008)
2008 49	Estimation of mean pulmonary artery pressure: simpler than expected. [18321898] Chest 133(3): 592-3 (2008)
2005 50	Pulmonary arterial hypertension: the key role of echocardiography. [15888866] Chest 127(5): 1836-43 (2005)
2004 51	Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. [15249495] Chest 126(1 Suppl): 63S-71S (2004)
2004 52	Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. [15249494] Chest 126(1 Suppl): 35S-62S (2004)
2004 53	Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. [15249493] Chest 126(1 Suppl): 14S-34S (2004)
1984 54	Pulmonary hypertensive diseases. [6365477] Chest 85(3): 397-405 (1984)
1974 55	A problem in pulmonary hypertension. 2. The final course and autopsy findings. A clinicopathologic conference from the Division of Pulmonary Diseases, Hahnemann Medical College and Hospital, Philadelphia. [4810679] Chest 65(2): 192-7 (1974)
1971 56	A reconsideration of the origins of pulmonary hypertension. [5099816] Chest 59(1): 82-94 (1971)
2008 57	Pulmonary hypertension, right ventricular failure, and kidney: different from left ventricular failure? [18614776] Clin J Am Soc Nephrol 3(5): 1232-7 (2008)
2008 58	Biomarkers in pulmonary hypertension. [18669790] Eur Respir J 32(2): 503-12 (2008)
2008 59	Pulmonary hypertension in interstitial lung disease. [18515559] Eur Respir J 31(6): 1357-67 (2008)
2008 60	Prostacyclin therapies for the treatment of pulmonary arterial hypertension. [18378784] Eur Respir J 31(4): 891-901 (2008)
2008 61	Endothelin receptor antagonists in pulmonary arterial hypertension. [18238950] Eur Respir J 31(2): 407-15 (2008)
2008 62	Pulmonary hypertension: basic concepts and practical management. [18238945] Eur Respir J 31(2): 236-7 (2008)
2006 63	Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review. [17074918] Eur Respir J 28(5): 999-1004 (2006)
2005 64	Noninvasive assessment and monitoring of the pulmonary circulation. [15802353] Eur Respir J 25(4): 758-66 (2005)
2004 65	Chronic thromboembolic pulmonary hypertension. [15083767] Eur Respir J 23(4): 637-48 (2004)
2003 66	Pulmonary arterial hypertension in children. [12570125] Eur Respir J 21(1): 155-76 (2003)
2002 67	Pathobiology of pulmonary arterial hypertension. [12503718] Eur Respir J 20(6): 1559-72 (2002)
2002 68	Haemodynamic evaluation of pulmonary hypertension. [12449189] Eur Respir J 20(5): 1314-31 (2002)
2002 69	The new clinical trials on pharmacological treatment in pulmonary arterial hypertension. [12412701] Eur Respir J 20(4): 1037-49 (2002)
2002 70	Pulmonary hypertension in collagen vascular disease. [11936539] Eur Respir J 19(3): 571-6 (2002)
1999 71	Severe pulmonary hypertensive diseases: a perspective. [10624750] Eur Respir J 14(6): 1246-50 (1999)
1996 72	Medical management of primary pulmonary hypertension. [8947091] Eur Respir J 9(11): 2401-9 (1996)
1995 73	Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. [8666110] Eur Respir J 8(12): 2129-38 (1995)
1995 74	More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited. [8575567] Eur Respir J 8(9): 1445-9 (1995)
1994 75	Medical treatment of pulmonary hypertension in chronic lung disease. [8143814] Eur Respir J 7(1): 148-52 (1994)
2000 76	Diagnosis and treatment of pulmonary hypertension associated with collagen diseases. [10801140] Intern Med 39(4): 280-2 (2000)
2003 77	Pulmonary arterial hypertension--the primary pulmonary hypertension syndromes. [14509142] Isr Med Assoc J 5(4): 298-303 (2003)
2008 78	Molecular pathogenesis of pulmonary arterial hypertension. [18596905] J Clin Invest 118(7): 2372-9 (2008)
2009 79	Wide variation in clinicians' assessment of New York Heart Association/World Health Organization functional class in patients with pulmonary arterial hypertension. [19567712] Mayo Clin Proc 84(7): 586-92 (2009)
2007 80	Pulmonary hypertension in patients with interstitial lung diseases. [17352370] Mayo Clin Proc 82(3): 342-50 (2007)
2001 81	Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. [11484688] N Engl J Med 345(5): 319-24 (2001)
2009 82	Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation. [19825167] Respir Res 10(-): 95 (2009)
2007 83	Prognosis, screening, early detection and differentiation of arterial pulmonary hypertension. [17629802] Swiss Med Wkly 137(23-24): 331-6 (2007)
2007 84	Update on therapies for pulmonary hypertension. [17370143] Swiss Med Wkly 137(5-6): 73-82 (2007)
2006 85	Surgical treatment of chronic thromboembolic pulmonary hypertension. [16947087] Swiss Med Wkly 136(31-32): 491-7 (2006)
2003 86	Pulmonary hypertension. [12644956] Swiss Med Wkly 133(7-8): 103-10 (2003)
1999 87	Primary pulmonary hypertension. [10567632] Thorax 54(12): 1107-18 (1999)
2008 88	Pulmonary arterial hypertension. [18420094] J Am Coll Cardiol 51(16): 1527-38 (2008)
2004 89	Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. [15194183] J Am Coll Cardiol 43(12 Suppl S): 81S-88S (2004)
2004 90	Interventional and surgical modalities of treatment for pulmonary arterial hypertension. [15194182] J Am Coll Cardiol 43(12 Suppl S): 73S-80S (2004)
2004 91	Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension. [15194181] J Am Coll Cardiol 43(12 Suppl S): 68S-72S (2004)
2004 92	Endothelin receptor antagonists in pulmonary arterial hypertension. [15194180] J Am Coll Cardiol 43(12 Suppl S): 62S-67S (2004)
2004 93	Prostanoid therapy for pulmonary arterial hypertension. [15194179] J Am Coll Cardiol 43(12 Suppl S): 56S-61S (2004)
2004 94	End points and clinical trial designs in pulmonary arterial hypertension: clinical and regulatory perspectives. [15194178] J Am Coll Cardiol 43(12 Suppl S): 48S-55S (2004)
2004 95	Diagnosis and differential assessment of pulmonary arterial hypertension. [15194177] J Am Coll Cardiol 43(12 Suppl S): 40S-47S (2004)
2004 96	Genetic basis of pulmonary arterial hypertension: current understanding and future directions. [15194176] J Am Coll Cardiol 43(12 Suppl S): 33S-39S (2004)
2004 97	Pathologic assessment of vasculopathies in pulmonary hypertension. [15194175] J Am Coll Cardiol 43(12 Suppl S): 25S-32S (2004)
2004 98	Cellular and molecular pathobiology of pulmonary arterial hypertension. [15194174] J Am Coll Cardiol 43(12 Suppl S): 13S-24S (2004)
2004 99	Clinical classification of pulmonary hypertension. [15194173] J Am Coll Cardiol 43(12 Suppl S): 5S-12S (2004)
2007 100	Pulmonary arterial hypertension: a disease of tethers, SNAREs and SNAPs? [17416597] Am J Physiol Heart Circ Physiol 293(1): H77-85 (2007)
2007 101	The hyperproliferative endothelial cell phenotype in idiopathic pulmonary arterial hypertension. [17601794] Am J Physiol Lung Cell Mol Physiol 293(3): L546-7 (2007)
2006 102	Mediators and modulators of pulmonary arterial hypertension. [16698850] Am J Physiol Lung Cell Mol Physiol 291(4): L547-58 (2006)
2008 103	Diagnosis and treatment of secondary (non-category 1) pulmonary hypertension. [19015413] Circulation 118(21): 2190-9 (2008)
2008 104	Exercise-induced pulmonary arterial hypertension: a new addition to the spectrum of pulmonary vascular diseases. [19015412] Circulation 118(21): 2120-1 (2008)
2008 105	Emerging concepts and translational priorities in pulmonary arterial hypertension. [18824655] Circulation 118(14): 1486-95 (2008)
2008 106	Uncertainties in the diagnosis and treatment of pulmonary arterial hypertension. [18779455] Circulation 118(11): 1195-201 (2008)
2006 107	Pulmonary arterial hypertension. [17000921] Circulation 114(13): 1417-31 (2006)
2006 108	Chronic thromboembolic pulmonary hypertension. [16636189] Circulation 113(16): 2011-20 (2006)
2009 109	A meta-analysis of randomized controlled trials in pulmonary arterial hypertension. [19155250] Eur Heart J 30(4): 394-403 (2009)
2004 110	Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. [15589643] Eur Heart J 25(24): 2243-78 (2004)
2001 111	Pulmonary arterial hypertension: new ideas and perspectives. [11250981] Heart 85(4): 475-80 (2001)
1998 112	Pulmonary thromboendarterectomy. [9538301] Heart 79(2): 118-20 (1998)
1988 113	Pulmonary hypertension complicating portal hypertension: findings on chest radiographs. [3263020] AJR Am J Roentgenol 151(5): 909-14 (1988)
1987 114	MR imaging of pulmonary arterial hypertension and pulmonary emboli. [3495975] AJR Am J Roentgenol 149(1): 15-21 (1987)
2006 115	Congenital and acquired pulmonary artery anomalies in the adult: radiologic overview. [16549603] Radiographics 26(2): 349-71 (2006)
2000 116	From the archives of the AFIP: pulmonary vasculature: hypertension and infarction. [10715347] Radiographics 20(2): 491-524; quiz 530-1, 532 (2000)
1989 117	Pulmonary arterial hypertension: a contemporary review. [2678297] Radiographics 9(5): 905-27 (1989)
2010 118	CT findings in diseases associated with pulmonary hypertension: a current review. [21057119] Radiographics 30(7): 1753-77 (2010)
2007 119	Pulmonary hypertension: accuracy of detection with left ventricular septal-to-free wall curvature ratio measured at cardiac MR. [17392248] Radiology 243(1): 63-9 (2007)
2007 120	Pulmonary arterial hypertension: noninvasive detection with phase-contrast MR imaging. [17329691] Radiology 243(1): 70-9 (2007)
2010 121	Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination. [20093532] Radiology 254(2): 609-16 (2010)
2004 122	A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism. [15308510] Ann Rheum Dis 63(9): 1009-14 (2004)
2008 123	Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer. [18083891] Am J Physiol Heart Circ Physiol 294(2): H570-8 (2008)
2008 124	Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension. [18790993] Am J Physiol Lung Cell Mol Physiol 295(6): L979-87 (2008)
2009 125	Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. [19748998] Am J Physiol Lung Cell Mol Physiol 297(6): L1013-32 (2009)
2008 126	Caveolin-1: a critical regulator of pulmonary vascular architecture and nitric oxide bioavailability in pulmonary hypertension. [18296499] Am J Physiol Lung Cell Mol Physiol 294(5): L862-4 (2008)
2008 127	Increased pulmonary vascular resistance and defective pulmonary artery filling in caveolin-1-/- mice. [18192592] Am J Physiol Lung Cell Mol Physiol 294(5): L865-73 (2008)
2007 128	Pulmonary vasodilators. [17594732] Respir Care 52(7): 885-99 (2007)
2010 129	Prognosis of pulmonary arterial hypertension: the power of clinical registries of rare diseases. [20585007] Circulation 122(2): 106-8 (2010)
2010 130	Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. [20458021] Circulation 121(18): 2045-66 (2010)
2004 131	Endothelial dysfunction in pulmonary hypertension. [14734504] Circulation 109(2): 159-65 (2004)
2009 132	ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. [19332472] Circulation 119(16): 2250-94 (2009)
2005 133	Tetrahydrobiopterin in pulmonary hypertension: pulmonary hypertension in guanosine triphosphate-cyclohydrolase-deficient mice. [15851611] Circulation 111(16): 2022-4 (2005)
2009 134	Evidence for inflammatory signaling in idiopathic pulmonary artery hypertension: TRPC6 and nuclear factor-kappaB. [19414653] Circulation 119(17): 2297-8 (2009)
2008 135	Inoperable chronic thromboembolic pulmonary hypertension: treatable with medical therapy. [18682450] Chest 134(2): 221-3 (2008)
2004 136	Pulmonary artery hypertension and sleep-disordered breathing: ACCP evidence-based clinical practice guidelines. [15249496] Chest 126(1 Suppl): 72S-77S (2004)
2007 137	Pulmonary hypertension: from an orphan disease to a public health problem. [17699126] Chest 132(2): 365-7 (2007)
2007 138	Pulmonary hypertension in idiopathic pulmonary fibrosis. [17873194] Chest 132(3): 998-1006 (2007)
2007 139	How do we explain unexplained pulmonary hypertension in the elderly? [17218548] Chest 131(1): 5-6 (2007)
2009 140	The right ventricle under pressure: cellular and molecular mechanisms of right-heart failure in pulmonary hypertension. [19265089] Chest 135(3): 794-804 (2009)
2007 141	Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. [17356077] Chest 131(3): 657-63 (2007)
2007 142	Angiogenesis in chronic lung disease. [17356107] Chest 131(3): 874-9 (2007)
2007 143	The impact of pulmonary arterial hypertension on idiopathic pulmonary fibrosis. [17356072] Chest 131(3): 641-3 (2007)
2007 144	Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. [17565025] Chest 131(6): 1917-28 (2007)
2009 145	Endovascular therapy for left main compression syndrome. Case report and literature review. [19497900] Chest 135(6): 1648-50 (2009)
2009 146	Evaluating health-related quality of life, work ability, and disability in pulmonary arterial hypertension: an unmet need. [19666759] Chest 136(2): 597-603 (2009)
2005 147	Treatment for secondary pulmonary hypertension. [16236830] Chest 128(4): 1897-8 (2005)
2005 148	Pulmonary hypertension: cellular and molecular mechanisms. [16373828] Chest 128(6 Suppl): 565S-571S (2005)
2006 149	Thrombotic arteriopathy and anticoagulation in pulmonary hypertension. [16899857] Chest 130(2): 545-52 (2006)
2011 150	Pulmonary arterial hypertension associated with connective tissue disease and immunosuppressive therapy. [21963571] Circ J 75(11): 2543-4 (2011)
2011 151	Recent progress in the management of pulmonary hypertension. [21747194] Circ J 75(8): 1801-10 (2011)
2010 152	Dose-dependent reduction in pulmonary vascular resistance with epoprostenol in pulmonary arterial hypertension. [20838003] Circ J 74(10): 2062-3 (2010)
2009 153	Are adrenergic receptor blockers effective or contraindicated in pulmonary arterial hypertension? [19940372] Circ J 73(12): 2212-3 (2009)
2009 154	Rho-kinase activation in patients with pulmonary arterial hypertension. [19706987] Circ J 73(9): 1597-8 (2009)
2010 155	Novel approaches to treat experimental pulmonary arterial hypertension: a review. [20339474] J Biomed Biotechnol 2010(-): 702836 (2010)
2005 156	Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol. [16055621] Thorax 60(12): 1025-30 (2005)
2005 157	The endothelin system and its role in pulmonary arterial hypertension (PAH). [15923241] Thorax 60(6): 443-4 (2005)
2005 158	Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment. [15994270] Thorax 60(7): 605-9 (2005)
2010 159	Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses. [20504865] Eur Heart J 31(17): 2080-6 (2010)
2008 160	Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter? [18562303] Eur Heart J 29(16): 1936-48 (2008)
2009 161	Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). [19713419] Eur Heart J 30(20): 2493-537 (2009)
2009 162	Developing new guidelines for the diagnosis and treatment of pulmonary hypertension. [19842237] Eur Heart J 30(20): 2416-8 (2009)
2011 163	New perspectives for the treatment of pulmonary hypertension. [21175577] Br J Pharmacol 163(1): 125-40 (2011)
2008 164	Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications. [18084317] Br J Pharmacol 153 Suppl 1(-): S99-S111 (2008)
2006 165	Pulmonary arterial hypertension (PAH) in connective tissue diseases. [16987822] Rheumatology (Oxford) 45 Suppl 3(-): iii11-3 (2006)
2008 166	Right ventricular function in scleroderma-related pulmonary hypertension. [18784141] Rheumatology (Oxford) 47 Suppl 5(-): v42-3 (2008)
2008 167	Outcome measures in pulmonary arterial hypertension associated with systemic sclerosis. [18784140] Rheumatology (Oxford) 47 Suppl 5(-): v39-41 (2008)
2008 168	Screening for PAH in patients with systemic sclerosis: focus on Doppler echocardiography. [18784138] Rheumatology (Oxford) 47 Suppl 5(-): v33-5 (2008)
2006 169	Primary pulmonary arterial hypertension and the systemic autoimmune diseases. [16671366] Isr Med Assoc J 8(4): 277-9 (2006)
2002 170	New treatments for pulmonary arterial hypertension. [11991870] Am J Respir Crit Care Med 165(9): 1209-16 (2002)
2010 171	Update on pulmonary hypertension 2009. [20460546] Am J Respir Crit Care Med 181(10): 1020-6 (2010)
2003 172	Hemolytic anemia-associated pulmonary hypertension of sickle cell disease and the nitric oxide/arginine pathway. [12826592] Am J Respir Crit Care Med 168(1): 3-4 (2003)
2007 173	Sickle cell disease-associated pulmonary hypertension: a coat of many colors. [17545455] Am J Respir Crit Care Med 175(12): 1218-9 (2007)
2007 174	Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. [17255562] Am J Respir Crit Care Med 175(9): 875-80 (2007)
2003 175	Autoimmune aspects of pulmonary hypertension in collagen vascular diseases. [14714951] Intern Med 42(12): 1163-4 (2003)
2007 176	Peripheral pulmonary artery aneurysms in patients with pulmonary artery hypertension. [17603237] Intern Med 46(13): 979-84 (2007)
2008 177	Pulmonary hypertension: an increasingly recognized complication of hereditary hemolytic anemias and HIV infection. [18212317] JAMA 299(3): 324-31 (2008)
2009 178	Endothelin receptor antagonist therapy in congenital heart disease with shunt-associated pulmonary arterial hypertension: a qualitative systematic review. [19279988] Can J Cardiol 25(3): e63-8 (2009)
2007 179	Pulmonary arterial hypertension: the mandatory role of the cardiologist. [17629174] Hellenic J Cardiol 48(3): 123-6 (2007)
2005 180	Recent advances in the treatment of pulmonary hypertension. [15981551] Hellenic J Cardiol 46(3): 165-73 (2005)
2005 181	Biochemical markers in the management of pulmonary hypertension. [15729606] Swiss Med Wkly 135(3-4): 43-9 (2005)
2007 182	The endothelium and genetics in pulmonary arterial hypertension. [17705107] Swiss Med Wkly 137(31-32): 437-42 (2007)
2011 183	Prognostic value of echocardiographic right/left ventricular end-diastolic diameter ratio in idiopathic pulmonary arterial hypertension. [21740775] Chin Med J (Engl) 124(11): 1672-7 (2011)
2011 184	Pulmonary arterial hypertension: a comparison between children and adults. [21357924] Eur Respir J 37(3): 665-77 (2011)
2010 185	Endothelial progenitors in pulmonary hypertension: new pathophysiology and therapeutic implications. [20123847] Eur Respir J 35(2): 418-25 (2010)
2010 186	Beyond arterial remodelling: pulmonary venous and cardiac involvement in patients with systemic sclerosis-associated pulmonary arterial hypertension. [20044455] Eur Respir J 35(1): 6-8 (2010)
2009 187	Soluble guanylate cyclase stimulators as a potential therapy for PAH: enthusiasm, pragmatism and concern. [19336588] Eur Respir J 33(4): 717-21 (2009)
2005 188	Autoimmunity and pulmonary hypertension: a perspective. [16319344] Eur Respir J 26(6): 1110-8 (2005)
2005 189	Pulmonary arterial hypertension: an autoimmune disease? [16319325] Eur Respir J 26(6): 986-8 (2005)
2009 190	Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension. [19797668] Eur Respir J 34(4): 792-4 (2009)
2009 191	The new definition of pulmonary hypertension. [19797667] Eur Respir J 34(4): 790-1 (2009)
2009 192	End-points and clinical trial design in pulmonary arterial hypertension: have we made progress? [19567606] Eur Respir J 34(1): 231-42 (2009)
2011 193	The image of pulmonary hypertension. [21755196] J Bras Pneumol 37(3): 283-4 (2011)
2010 194	Diagnosis and treatment of pulmonary hypertension: an update. [21225184] J Bras Pneumol 36(6): 795-811 (2010)
2007 195	Sickle cell anemia-associated pulmonary arterial hypertension. [18026658] J Bras Pneumol 33(5): 583-91 (2007)
2008 196	Testing pulmonary vasoreactivity. [19009218] J Bras Pneumol 34(10): 838-44 (2008)
2002 197	The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis? [12430958] J Anat 201(4): 335-48 (2002)
2006 198	Treatment of pulmonary arterial hypertension. [17136291] J Pediatr (Rio J) 82(5 Suppl): S153-65 (2006)
2010 199	Pulmonary hypertension in congenital shunts. [20875358] Rev Esp Cardiol 63(10): 1179-93 (2010)
2010 200	Current diagnostic and prognostic assessment of pulmonary Hypertension. [20450852] Rev Esp Cardiol 63(5): 583-96 (2010)
2010 201	Imaging techniques and the evaluation of the right heart and the pulmonary circulation. [20109418] Rev Esp Cardiol 63(2): 209-23 (2010)
2010 202	Prostacyclin therapy for pulmonary arterial hypertension. [20844610] Tex Heart Inst J 37(4): 391-9 (2010)
2009 203	Mechanisms of hypoxic pulmonary vasoconstriction and their roles in pulmonary hypertension: new findings for an old problem. [19297247] Curr Opin Pharmacol 9(3): 287-96 (2009)
2007 204	Dysfunctional intracellular trafficking in the pathobiology of pulmonary arterial hypertension. [17363775] Am J Respir Cell Mol Biol 37(1): 31-7 (2007)
2005 205	One hundred years of research in the pathogenesis of pulmonary hypertension. [16234331] Am J Respir Cell Mol Biol 33(5): 425-31 (2005)
2010 206	Pulmonary hypertension in women. [21090930] Expert Rev Cardiovasc Ther 8(11): 1549-58 (2010)
2008 207	Pathogenic mechanisms of pulmonary arterial hypertension. [17950310] J Mol Cell Cardiol 44(1): 14-30 (2008)
2010 208	Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension. [20531962] Drug Des Devel Ther 4(-): 61-70 (2010)
2010 209	Idiopathic pulmonary arterial hypertension. [20427556] Dis Model Mech 3(5-6): 268-73 (2010)
2012 210	Upregulation of osmo-mechanosensitive TRPV4 channel facilitates chronic hypoxia-induced myogenic tone and pulmonary hypertension. [22207590] Am J Physiol Lung Cell Mol Physiol 302(6): L555-68 (2012)
2009 211	A novel insight into the mechanism of pulmonary hypertension involving caveolin-1 deficiency and endothelial nitric oxide synthase activation. [20382348] Trends Cardiovasc Med 19(7): 238-42 (2009)
2005 212	Canadian Cardiovascular Society and Canadian Thoracic Society position statement on pulmonary arterial hypertension. [16247528] Can Respir J 12(6): 303-15 (2005)
2010 213	Diagnosis and management of pulmonary hypertension in systemic sclerosis. [20425528] Curr Rheumatol Rep 12(1): 8-18 (2010)
2011 214	Recent progress in understanding pediatric pulmonary hypertension. [21572384] Curr Opin Pediatr 23(3): 298-304 (2011)
2007 215	Systematic review of randomised, double-blind clinical trials of oral agents conducted in patients with pulmonary arterial hypertension. [17877662] Int J Clin Pract 61(10): 1756-65 (2007)
2008 216	Tadalafil: the evidence for its clinical potential in the treatment of pulmonary arterial hypertension. [21221188] Core Evid 2(4): 225-31 (2008)
2011 217	Evaluation of pulmonary arterial hypertension: invasive or noninvasive? [20473785] Int J Cardiovasc Imaging 27(7): 943-5 (2011)
2009 218	Therapy for pulmonary arterial hypertension associated with systemic sclerosis. [19667994] Curr Opin Rheumatol 21(6): 642-8 (2009)
2010 219	Heart failure and pulmonary hypertension. [20347789] Heart Fail Clin 6(2): 215-22 (2010)
2010 220	Noninvasive assessment of pulmonary artery pressures: moving beyond tricuspid regurgitation velocities. [20233861] Circ Cardiovasc Imaging 3(2): 132-3 (2010)
2010 221	Perioperative management of pulmonary hypertension. [20442537] Ann Card Anaesth 13(2): 89-91 (2010)
2008 222	Current status of bosentan for treatment of pulmonary hypertension. [18182753] Ann Card Anaesth 11(1): 6-14 (2008)
2010 223	Phosphodiesterase-5 inhibitors in management of pulmonary hypertension: safety, tolerability, and efficacy. [21701627] Drug Healthc Patient Saf 2(-): 151-61 (2010)
2009 224	Cellular and molecular basis of pulmonary arterial hypertension. [19555855] J Am Coll Cardiol 54(1 Suppl): S20-31 (2009)
2010 225	Contemporary insights into the pathogenesis, diagnosis and therapy of pulmonary arterial hypertension. [21135983] Cardiovasc J Afr 21(6): 334-7 (2010)
2007 226	Mechanisms controlling vascular tone in pulmonary arterial hypertension: implications for vasodilator therapy. [17148943] Pharmacology 79(2): 65-75 (2007)
2011 227	Recent trends in pulmonary arterial hypertension. [21654985] Lung India 28(1): 39-48 (2011)
2011 228	Phosphodiesterases: emerging therapeutic targets for neonatal pulmonary hypertension. [21695644] Handb Exp Pharmacol -(204): 251-77 (2011)
2008 229	Pulmonary hypertension: past, present and future. [19561874] Ann Thorac Med 3(1): 1-4 (2008)
2009 230	Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. [18950791] J Pediatr 154(3): 379-84, 384.e1-2 (2009)
2011 231	Overview of current therapeutic approaches for pulmonary hypertension. [22034603] Pulm Circ 1(2): 138-59 (2011)
2011 232	Diagnosis and assessment of pulmonary vascular disease by Doppler echocardiography. [22034604] Pulm Circ 1(2): 160-81 (2011)
2011 233	Lung transplantation for pulmonary hypertension. [22034605] Pulm Circ 1(2): 182-91 (2011)
2011 234	Pulmonary vascular wall stiffness: An important contributor to the increased right ventricular afterload with pulmonary hypertension. [22034607] Pulm Circ 1(2): 212-23 (2011)
2011 235	Pulmonary hypertension related to left-sided cardiac pathology. [21660234] Pulm Med 2011(-): 381787 (2011)
2008 236	Nitric oxide and beyond: new insights and therapies for pulmonary hypertension. [19057613] J Perinatol 28 Suppl 3(-): S67-71 (2008)
2010 237	Initial Experience with Sildenafil, Bosentan, and Nitric Oxide for Pediatric Cardiomyopathy Patients with Elevated Pulmonary Vascular Resistance before and after Orthotopic Heart Transplantation. [20224752] J Transplant 2010(-): 656984 (2010)
2007 238	Pathology of pulmonary hypertension. [17338926] Clin Chest Med 28(1): 23-42, vii (2007)
2008 239	Pulmonary hypertension caused by sarcoidosis. [18539244] Clin Chest Med 29(3): 549-63, x (2008)
2011 240	Assessment of right ventricular structure and function in pulmonary hypertension. [22073320] J Cardiovasc Ultrasound 19(3): 115-25 (2011)
2009 241	Utility of d-dimer in the diagnosis of patients with chronic thromboembolic pulmonary hypertension. [19572023] Open Respir Med J 3(-): 85-9 (2009)
2010 242	Assessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registry. [20549685] Catheter Cardiovasc Interv 76(6): 865-73 (2010)
2010 243	New approaches to the treatment of pulmonary hypertension: from bench to bedside. [20160533] Cardiol Rev 18(2): 76-84 (2010)
2009 244	Integrated care and optimal management of pulmonary arterial hypertension. [21197349] J Multidiscip Healthc 2(-): 67-78 (2009)
2010 245	Prostacyclin in the intensive care setting. [20216163] Pediatr Crit Care Med 11(2 Suppl): S41-5 (2010)
2010 246	Neonatal pulmonary hypertension. [20216169] Pediatr Crit Care Med 11(2 Suppl): S79-84 (2010)
2007 247	Pulmonary hypertension in sickle cell disease: relevance to children. [17454785] Pediatr Hematol Oncol 24(3): 159-70 (2007)
2010 248	Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy? [20170553] BMC Cardiovasc Disord 10(-): 9 (2010)
2007 249	Pulmonary hypertension: clinical manifestations, classification and diagnosis. [17663672] Int J Clin Pract Suppl -(156): 5-14 (2007)
2007 250	Imaging of the heart in pulmonary hypertension. [17663673] Int J Clin Pract Suppl -(156): 15-26 (2007)
2007 251	Pulmonary hypertension and the serotonin hypothesis: where are we now? [17663674] Int J Clin Pract Suppl -(156): 27-31 (2007)
2004 252	Calcium and TRP channels in pulmonary vascular smooth muscle cell proliferation. [15016901] News Physiol Sci 19(-): 44-50 (2004)
2010 253	Mitochondrial metabolic adaptation in right ventricular hypertrophy and failure. [20820751] J Mol Med (Berl) 88(10): 1011-20 (2010)
2010 254	Reversible or irreversible remodeling in pulmonary arterial hypertension. [20008280] Am J Respir Cell Mol Biol 43(6): 629-34 (2010)
2011 255	Nitrite in pulmonary arterial hypertension: therapeutic avenues in the setting of dysregulated arginine/nitric oxide synthase signalling. [21177703] Cardiovasc Res 89(3): 542-52 (2011)
2010 256	Management of severe pulmonary arterial hypertension. [21119186] Eur Respir Rev 19(118): 279-87 (2010)
2010 257	Treat-to-target strategies in pulmonary arterial hypertension: the importance of using multiple goals. [21119185] Eur Respir Rev 19(118): 272-8 (2010)
2010 258	Contemporary issues in pulmonary hypertension. [21119184] Eur Respir Rev 19(118): 266-71 (2010)
PMC 259	IL-13 receptor alpha2-arginase 2 pathway mediates IL-13-induced pulmonary hypertension. [23125252] Am J Physiol Lung Cell Mol Physiol 304(2):L112-24 (2013)
PMC 260	Modern age pathology of pulmonary arterial hypertension. [22679007] Am J Respir Crit Care Med 186(3):261-72 (2012)
PMC 261	Pathophysiology, management, and outcome of persistent pulmonary hypertension of the newborn: a clinical review. [24400269] Front Pediatr 1():23 (2013)
PMC 262	Bosentan and sildenafil in the treatment of HIV-associated pulmonary hypertension. [24470911] Infect Dis Rep 3(2):e14 (2011)
PMC 263	A possible role for systemic hypoxia in the reactive component of pulmonary hypertension in heart failure. [23273594] J Card Fail 19(1):50-9 (2013)
PMC 264	Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia. [23328924] J Perinatol 33(7):553-7 (2013)
PMC 265	A novel channelopathy in pulmonary arterial hypertension. [23883380] N Engl J Med 369(4):351-61 (2013)
PMC 266	Clinical safety, pharmacokinetics, and efficacy of ambrisentan therapy in children with pulmonary arterial hypertension. [22511577] Pediatr Pulmonol 48(1):27-34 (2013)
PMC 267	Pulmonary Arterial Hypertension in Patients with Primary Sjogren's Syndrome. [24511390] Autoimmune Dis 2014():710401 (2014)
PMC 268	Tezosentan increases nitric oxide signaling via enhanced hydrogen peroxide generation in lambs with surgically induced acute increases in pulmonary blood flow. [22961736] J Cell Biochem 114(2):435-47 (2013)
PMC 269	Altered expression and signal transduction of endothelin-1 receptors in heritable and idiopathic pulmonary arterial hypertension. [22688668] J Cell Physiol 228(2):322-9 (2013)
PMC 270	CXCR4 inhibition ameliorates severe obliterative pulmonary hypertension and accumulation of C-kit(+) cells in rats. [24587052] PLoS One 9(2):e89810 (2014)
PMC 271	Metabolomic heterogeneity of pulmonary arterial hypertension. [24533144] PLoS One 9(2):e88727 (2014)
PMC 272	Milrinone relaxes pulmonary veins in guinea pigs and humans. [24498166] PLoS One 9(1):e87685 (2014)
PMC 273	Inhalation of the BK(Ca)-opener NS1619 attenuates right ventricular pressure and improves oxygenation in the rat monocrotaline model of pulmonary hypertension. [24497961] PLoS One 9(1):e86636 (2014)
PMC 274	Current challenges in pediatric pulmonary hypertension. [24037630] Semin Respir Crit Care Med 34(5):627-44 (2013)
PMC 275	Noninvasive assessment of right heart function and hemodynamics during exercise in patients with pulmonary arterial hypertension. [23380750] South Med J 106(2):141-6 (2013)
PMC 276	Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension. [23590310] Am J Respir Cell Mol Biol 49(3):403-9 (2013)
PMC 277	Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study. [23111998] Eur J Heart Fail 15(3):277-83 (2013)
PMC 278	Vascular remodeling in pulmonary hypertension. [23334338] J Mol Med (Berl) 91(3):297-309 (2013)
PMC 279	FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate. [23247844] J Mol Med (Berl) 91(3):333-46 (2013)
PMC 280	Potential therapeutic targets for hypoxia-induced pulmonary artery hypertension. [24507703] J Transl Med 12():39 (2014)
PMC 281	Diminazene attenuates pulmonary hypertension and improves angiogenic progenitor cell functions in experimental models. [23370913] Am J Respir Crit Care Med 187(6):648-57 (2013)
PMC 282	Upregulated copper transporters in hypoxia-induced pulmonary hypertension. [24614111] PLoS One 9(3):e90544 (2014)
PMC 283	Vascular repair and regeneration as a therapeutic target for pulmonary arterial hypertension. [23594605] Respiration 85(5):355-64 (2013)
PMC 284	PGC1alpha-mediated mitofusin-2 deficiency in female rats and humans with pulmonary arterial hypertension. [23449689] Am J Respir Crit Care Med 187(8):865-78 (2013)
PMC 285	Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. [23114789] Circulation 126(22):2601-11 (2012)
PMC 286	Weaning from intravenous prostanoids and normalization of hemodynamics by long-term imatinib therapy in severe idiopathic pulmonary arterial hypertension. [24287663] Int J Clin Pharm 36(2):256-60 (2014)
PMC 287	Clinical implications of haemoptysis in patients with pulmonary arterial hypertension. [22943513] Int J Clin Pract Suppl (177):5-12 (2012)
PMC 288	Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension. [23353807] J Control Release 167(2):189-99 (2013)
PMC 289	Apelin-APJ signaling: a potential therapeutic target for pulmonary arterial hypertension. [24608803] Mol Cells 37(3):196-201 (2014)
PMC 290	A new era of therapeutic strategies for chronic thromboembolic pulmonary hypertension by two different interventional therapies; pulmonary endarterectomy and percutaneous transluminal pulmonary angioplasty. [24728482] PLoS One 9(4):e94587 (2014)
PMC 291	Inflammatory cytokines in pulmonary hypertension. [24739042] Respir Res 15():47 (2014)
PMC 292	PPARgamma as a potential therapeutic target in pulmonary hypertension. [20530063] Ther Adv Respir Dis 4(3):143-60 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Pulmonary hypertension.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Pulmonary hypertension.php on line 92